NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets form) + Clopidogrel Bisulphate IP eq. to Clopidogrel IP 75 mg

Jun 11, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 10, 2024, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets form) + Clopidogrel Bisulphate IP eq. to Clopidogrel IP 75 mg.

The following has been stated: -

•Each hard gelatin Capsule Contains Atorvastatin Calcium IP eq. to Atorvastatin 20 mg (as pellets form) + Clopidogrel Bisulphate IP eq. to Clopidogrel IP 75 mg (as pellets form) for M/s. Aeon Formulations Pvt. Ltd. (Manufacturer) & M/s Ipca Laboratories Ltd. (Marketer) and the retail price is 19.05 (Rs.)

[Notification No. 19(4053) /2024/DP/NPPA/DIV.III/8269/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT